Posted: Sep 15, 2010 3:34 PM by Melissa Canone
WASHINGTON (AP) - Federal health advisers are split over whether
to withdraw the diet pill Meridia due to evidence that it increases
heart attack and stroke risks, worrisome signs that led European
regulators to ban the drug earlier this year.
A panel of Food and Drug Administration advisers voted 8-8 on
whether to allow continued marketing of the drug. Panelists who
said the drug should stay on the market favored new warnings and
The agency is not required to follow the group's advice, though
it often does.
Meridia has been sold since 1997, but data released in November
showed patients with pre-existing heart disease were more likely to
suffer traumatic cardiovascular events. European regulators
withdrew the drug in January.